Pubblicazioni (scarica PDF) - Istituto Nazionale dei Tumori

Lista delle pubblicazioni scientifiche su riviste nazionali e internazionali* Con IMPACT FACTOR1. V. VENTAFRIDDA, M. TAMBURINI, F. DE CONNO: Comprehensive treatment in cancer pain.Advances in Pain Research and therapy. New York, Vol.9, 617- 628, 19852. V. VENTAFRIDDA, M. TAMBURINI, S. SELMI, L. VALERA, F. DE CONNO: The importance of ahome care program for patients with advanced cancer pain. Tumori, 71, 449-454, 19853. Ventafridda V., Spoldi E, Caraceni A, Tamburini M, De Conno F: The importance of continuoussubcutaneous morphine administration for cancer pain control. Pain Clinic 1: 47-55, 1986. (IF 0)4. V. VENTAFRIDDA, F. DE CONNO, M. TAMBURINI, M. PAPPALETTERA: Clinical evaluation ofchronic infusion of intrathecal morphine in cancer pain. Advances in Pain Research and Therapy,Vol. 8, 391-397, 19865. V. VENTAFRIDDA, M. TAMBURINI, S. SELMI, F. DE CONNO: Pain and quality of life assesmentin advanced cancer patients. In: Pain and quality of life assessment in advanced cancer patients(Ventafridda, Van Dam, Yancik, Tamburini) Excerpta medica, Amsterdam, 183-192, 19866. Ventafridda V, Oliveri E., Caraceni A et al.: A retrospective study on the use of oral morphine incancer pain. J Pain Sympt Manag 2: 77-81, 1987. (IF 0)7. M. TAMBURINI, S. SELMI, F. DE CONNO, V. VENTAFRIDDA: Semantic descriptors of pain.Pain, 187-193, 19878. V. VENTAFRIDDA, C. RIPAMONTI, F. DE CONNO, M. BIANCHI, F. PAZZUCCONI, A. PANERAI:Antidepressants increase bioavailability of morphine in cancer patients. The Lancet, May 23, 19879. V. VENTAFRIDDA, S. SELMI, G. DI MOLA, M. TAMBURINI, F. DE CONNO: A new model ofcontinuing care for advanced cancer pain treatment. The Hospice Journal, 85-99, 198710. Ventafridda V, Tamburini M, Caraceni A et al.: A validation study of the WHO method for cancerpain relief. Cancer 59: 850-857, 1987. (IF 2,343)11. Ventafridda V, Spoldi E, Caraceni A, De Conno F: Intraspinal morphine for cancer pain. ActaAnaestesiol Scand 31, S85: 47-53, 1987. (IF 0,974)12. Caraceni A: Availability and use of opioids for cancer pain patients in Italy. J Pain Sympt Manag2: 127-128, 1987 * (IF 0)13. Ventafridda V, Bonezzi C, Caraceni A et al.: Antidepressants for cancer pain and other painfulsyndromes with deafferentation component: comparison of amytriptiline and trazodone. It JNeurol Sci 8: 579-587, 1987. (IF 0,189)14. F. DE CONNO, L. SAITA, V. VENTAFRIDDA: La thermocoagulation controlee au niveau de L5-S1 dans les algies perineales dues a un cancer avance. Douleur e Analgesie, 1, 79-82, 198815. V. VENTAFRIDDA, E. SPOLDI, F. DE CONNO, A. CARACENI: Trattamento farmacologico deldolore cronico da cancro: gli oppioidi. Argomenti di Oncologia, 9, 213-221, 198816. U. VERONESI, F. DE CONNO, M. GALLUCCI, V. VENTAFRIDDA: Dolore e terapia del dolore.Enciclopedia del novecento. Vol. VIII, 754-763, 198917. V. VENTAFRIDDA, L. SAITA, L. BARLETTA, F. DE CONNO: Clinical observations on controlled1

elease morphine in cancer pain. Journal of pain and symptom management. Vol. 4, 124-129,198918. V. VENTAFRIDDA, E. SPOLDI, F. DE CONNO: The control of dyspnea in advanced cancerpatients. Chest, Vol.98, 6, 1544, 199019. V. VENTAFRIDDA, F. DE CONNO, C. RIPAMONTI, A. GAMBA, M. TAMBURINI: Quality of lifeassesment during a palliative care programme. Annals of oncology. 1: 415-420, 199020. V. VENTAFRIDDA, M. BIANCHI, C. RIPAMONTI, P. SACERDOTE, F. DE CONNO, E. ZECCA, A.PANERAI: Studies on the effects of antidepressant drugs on the antinociceptive action ofmorphine and on plasma morphine in rat and man. Pain. 43, 155-162, 199021. V. VENTAFRIDDA, A. SBANOTTO, F. DE CONNO: Pain in prostatic cancer. Palliative Medicine.4, 173-184, 199022. V. VENTAFRIDDA, F. TOSCANI, M. TAMBURINI, O. CORLI, M. GALLUCCI, A. GOTTLIEB, R.SPERANZA, F. DE CONNO: Sodium naproxen vs. diclofenac in cancer pain control. Arzneim.Forsch. Drug Res. 40, 1132-1134, 199023. Ventafridda GV, Caraceni AT, Sbanotto A, Barletta L, De Conno F: pain treatment in cancer of thepancreas. Eur J Surg Oncol 16: 1 -6, 1990. * (IF 0)24. Ventafridda V, Ripamonti C, Caraceni A, Spoldi E, Messina L, De Conno F. The management ofgastrointestinal obstruction in terminal cancer patients. Tumori 76: 389-393, 1990. * (IF 0,571)25. Ventafridda V, Caraceni A, Martini C, Sbanotto A, De Conno F. On the significance of Lhermitte'ssign in Oncology. J Neurooncol 10: 133-137, 1991. (IF 1,063)26. Ventafridda V, Caraceni A. Cancer pain classification a controversial issue. Pain 46: 1-2, 1991. (IF3,492)27. De Conno F, Caraceni A, Martini C, Spoldi E, Salvetti M, Ventafridda V. Hyperalgesia andmyoclonus with high-dose intrathecal morphine. Pain 47: 337-339, 1991. (IF 3,492)28. De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafridda V. The continuous SC infusion ofhyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J PainSympt Manag 6: 484-486, 1991. (IF 0)29. De Conno F, Spoldi E, Caraceni A, Ventafridda V. Does pharmacological treatment affect thesensation of breathlessness in terminal cancer patients ? Palliative Medicine 5: 237-243 1991.(IF 0)30. F. DE CONNO, L. SAITA, V. VENTAFRIDDA: Skin problems in advanced and terminal cancerpatients. Journal of Pain and Symptoms Management. 6, 247-256, 199131. V. VENTAFRIDDA, F. DE CONNO, L. SAITA, C. RIPAMONTI, G.F. BARONZIO: Leucocytelymphocyteratio as prognostic indicator of survival in cachectic cancer patients. Annals ofoncology. 2: 196, 199132. F. DE CONNO, C. RIPAMONTI, A. SBANOTTO, L. BARLETTA, E. ZECCA, C. MARTINI, V.VENTAFRIDDA: A clinical study on the use of codeine, oxycodone, dextropropoxyphene,buprenorphine and pentazocine. J. of pain and symptom management.7, 423-427, 199133. M. TAMBURINI, S. ROSSO, A. GAMBA, E. MENCAGLIA, F. DE CONNO, V. VENTAFRIDDA: Atherapy impact questionnaire for quality of life assessment in advanced cancer research. Annalsof oncology, 3: 565-570, 199234. Caraceni A. Martini C., Belli F., Mascheroni L., Rivoltini L., Arienti F., Cascinelli N.2

Neuropsychological and neurophysiological assessment of Interleukin-2 administration. Eur JCancer, 29A: 1266-1269 1993 (IF 2,191)35. Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti M T. Octreotide in relievinggastrointestinal symptoms due to bowel obstruction. Palliative Medicine, 7: 255-299, 1993 (IF 0)36. F. DE CONNO, C. RIPAMONTI, A. SBANOTTO, L. SAITA, E. ZECCA, V. VENTAFRIDDA: Thepharmacological management of cancer pain: the role of non opioid and adjuvant drugs. Annals ofoncology, 4: 187-193, 199337. V. VENTAFRIDDA, F. DE CONNO, H. BLUMHUBER: The situation of palliative care in Europe.Journal of Pain and Symptom Management, Vol. 8, 6, 369-371, 199338. De Conno F., Caraceni A., Aldrighetti et al. Paraplegia following celiac plexus block. Pain 55:383-385, 1994. (IF 3,408)39. De Conno F, Caraceni A, Gamba A, et al . Pain measurement in cancer pain a comparison of sixmethods. Pain 57: 161-166, 1994. (IF 3,408)40. De Conno F, Zecca E, Martini C, Ripamonti C., Caraceni A, Saita L. Tolerability of ketorolacadministered via continuous subcutaneous infusion for cancer pain. J Pain Sympt Manage, 9:119-121, 1994. (IF 0,908)41. Caraceni A, Martini C, De Conno F, Ventafridda V Organic brain syndromes and opioidadministration for cancer pain J Pain Symp Manage 9: 527-533, 1994. * (IF 0,908)42. Capri G, Munzone E, Tarenzi E, Fulfaro F, Gianni L, Caraceni A, Martini C, Scaioli V. Opticnerve disturbances a new form of paclitaxel neurotoxicity. J Nat Cancer Institute , 86:1099-1101,1994. (IF 7,454)43. Bortolussi R, Fabiani F, Savron F, Testa V, Lazzarini R, Sorio R, De Conno F, Caraceni A Acutemorphine intoxication during high-dose recombinant iterleukin-2 treatment for metastatic renal celcancer. Eur J Cancer 30A: 1905-1907, 1994. (IF 1,959)44. Gianni L, Munzone E, Capri G, Villani F, Spreafico E, Tarenzi E, Fulfaro F, Caraceni A , MartiniC, Laffranchi A, Valagussa P, Bonadonna G. Paclitaxel in metastatic breast cancer: a trial of twodoses by 3-hour infusion in patients with disease recurrence after prior therapy withanthracyclines. J Nat Cancer Institute 87: 1169-1175, 1995. (IF 9,455)45. Scaioli V., Caraceni A, Martini C, Palazzini E, Tarenzi E, Fulfaro F, Munzone E. Visual evokedpotential findings in course of paclitaxel chemotherapy for breast cancer. Journal of Neurooncology,25: 221-225, 1995. (IF 1,096)46. Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, Spreafico C, Laffranchi A, CaraceniA, Martini C, Stefanelli M, Valagussa P, Bonadonna G. Paclitaxel 3-hour infusion in combinationwith bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacyand cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 13: 2688-2699,1995. (IF 7,507)47. Maltoni M, Pirovano M, Scarpi E, et al Prediction of survival patients terminally ill with cancer.Results of an Italian prospectivemulticentricstudy. Cancer 75: 2613-2623, 1995 vedi lista deicoautori (IF 0,773)48. 175) F. DE CONNO, C. RIPAMONTI, L. SAITA, T. MACEACHERN, J. HANSON, E. BRUERA:3

Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versusrectal morphine administration in opioid-naive cancer patients with pain. J. of Clin. Onc. Vol. 13,N. 4, 1004-1008, 199549. Caraceni A. Clinicopathological correlates of common cancer pain syndromesHematology/Oncology Clinics of North America, 10: 57-78, 1996. (IF 1,960)50. Terenziani, M, De Micheli , Brambilla , Ferrari, Moliterni, Zambetti M, Caraceni A, Martini C,Vinorelbine: a active non cross-resistant drug in advanced breast cancer a phase II Study. BreastCancer Research and Treatment 39: 285-291, 1996. * (IF 2,879)51. Caraceni A, Portenoy R K. Pain management in Pancreatic cancer. Cancer 78: 639-653, 1996.(IF 2,864)52. Caraceni A, Mendoza T, Mencaglia E, Baratella C., Edwards K, Forjaz MJ, Martini C, Serlin R,De Conno F, Cleeland C. A Validation Study of an Italian Version of the Brief Pain Inventory(Breve Questionario Per La Valutazione Del Dolore). Pain 65: 87-92, 1996. (IF 3,836)53. De Conno F, Caraceni A, Groff L, Brunelli C, Tamburini M, Donati I, Ventafridda VEffect of homecareon the place of death of advanced cancer patients Eur J Cancer 32A: 1142-1147, 1996.(IF 2,095)54. M. TAMBURINI, C. BRUNELLI, S. ROSSO, V. VENTAFRIDDA, contriburors F. DE CONNO et.al.: Prognostic value of quality of life scores in terminal cancer patients. J. of Pain and S. Man.Vol. 11, 1, 32-41, 199655. G. HANKS, F. DE CONNO , M. HANNA, H.J. Mc QUAY, S. MERCADANTE, J. MEYNADIER, P.POULAIN, C. RIPAMONTI, J. SAWE, R. TWYCROSS, A. VAINIO, D. ZECH: Morphine in cancerpain: Modes of administration. B.M.J. 312: 823-6, 1996.56. F. BOZZETTI, D. AMADORI, E. BRUERA, L. COZZAGLIO, O. CORLI, A. FILIBERTI, C.H.RAPIN, H. NEUENSCHWANDER, M. AOUN, S. BASSO RICCI, F. DE CONNO, R. DOCI, M.GARRONE, M. GENTILINI, N. LERY, M. MANTELL, R. SHELDON COLLINS, G. TROMPINO:Consensus meeting on artificial nutrition versus hydration in terminal cancer patients. Nutrition,vol12, 3, 169-172, 199657. C. RIPAMONTI, E. ZECCA, C. BRUNELLI, E. RIZZIO, L. SAITA, F. LODI, F. DE CONNO: Rectalmethadone in cancer patients with pain. Annals of oncology, 6, 841-843, 199558. V. VENTAFRIDDA, F. DE CONNO: Report on the activities of the Milan World HealthOrganization Collaborating Center. J.P.S.M. 2, 79-81, 199659. H. BLUMHUBER, F. DE CONNO, G.W. HANKS: Report of the European Association for PalliativeCare. J.P.S.M. 2, 82-84, 199660. Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, Gramazio R., Terzoli E, Luzzani M, DeMarinis F, Caraceni A., Labianca R. Biological indices predictive of survival in 519 Italianterminally-ill cancer patients. J Pain Symtpom Manage 13: 1-9, 1997. (IF 2,091)61. Caraceni A., Martini C, Spatti G, Thomas A, Onofrj Recovering optic neuritis during systemiccisplatin and carboplatin chemotherapy Acta Neurologica Scandinavica 96: 260-261, 1997. (IF1,068)62. Caraceni A., Martini C, Zecca E, De Conno F, Portenoy RK. Pain due to epidural tumor in cancerpatients report of two cases and differential diagnosis Italian Journal of Neurological Sciences 18:303-307, 1997. (IF 0,261)63. Formaglio F, Caraceni A Meningeal metastastes: clinical aspects and diagnosis. Ital J Neurol Sci4

19: 133-149, 1998. (IF 0,418)64. Caraceni A, Gangeri L, Martini C, Belli F, Brunelli C, Baldini M, Mascheroni L, Lenisa L, CascinelliN. Neurotoxicity of interferon-alpha in melanoma therapy. Results from a randomized controlledtrial. Cancer 83: 482-489, 1998. (IF 3,296)65. Caraceni A., Beltrami E, Borreani C, Grassi L. La diagnosi e la valutazione dello statoconfusionale acuto (delirium). Quaderni di Cure Palliative 6: 10-18, 1998 (IF 0)66. De Conno F, Martini C, Zecca E, Balzarini A, Venturino P, Groff L, Caraceni A. Megestroleacetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trialEur J Cancer 34: 1705-179, 1998. (IF 2,407)67. C. RIPAMONTI, E. ZECCA, C. BRUNELLI, F. FULFARO, S. VILLA, A. BALZARINI, E.BOMBARDIERI, F. DE CONNO: A randomized controlled clinical trial to evaluate the role of zincsulphate administration in cancer patients with taste alterations due to head and neck irradiation.Cancer, 1938-1945, 199868. C. RIPAMONTI, F. DE CONNO, L. GROFF, M. BELZILE, J. PEREIRA, J. HANSON, E. BRUERA:Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain:Comparison of two clinical experiences. Annals of Oncology, 9: 79-83, 199869. C. RIPAMONTI, L. GROFF, C. BRUNELLI, D. POLASTRI, A. STAVRAKIS, F. DE CONNO:Switching from morphine to oral methadonein treating cancer pain: what is the equianalgesic doseratio? J.C.O. vol.16, 10, 3216-3221, 199870. F. DE CONNO, R. BOFFI, L. SAITA: Eighteen years of home care: from assistance by phone to acomplete service within the health care system. Journal of Palliative Care, 14, 3, 91-93, 199871. A. BALZARINI, F. GARIBOLDI, F. DE CONNO: La riabilitazione. In: La patologia mammariadell'età senile ed. E.L.Galante. Il pensiero scientifico, 157-166, 199872. M. MERSON, A. BALZARINI, F. BOSELLO, F. VALESELLA, B. COTZA, M.G. BLANDINI, W.BORDET, P. CAMPANINI, L. CAVALLINI? R. CESTAROLLI, G. CHIMENTO, C. FICCARELLI, D.FICCHI, P. PLACUCCI, F. DE CONNO: Archery as a possible rehabilitative activity in theoncological structure: preliminary observations from a feasibility study. Tumori, 614-615, 84, 5,199873. Portenoy, R.K., Caraceni A., Cherny N I, Goldblum R, Ingham J, Inturrisi C.E., Johnson J.H.,Lapin J., Tiseo P.J., Kreek M.J. Dynorphin A(1-13) analgesia in opioid treated patients withchronic pain. A controlled pilot study. Clin Drug Invest 17: 33-42, 1999. (IF 0,710)74. Bohm S, Oriana S, Spatti G, Di Re F, Bresciani G, Pirovano C, Grosso I, Martini C, Caraceni A,Pilotti S, Zunino F. Dose intensification of platinum compounds with glutathione protection asinduction chemotherpy for advanced ovarian carcinoma. Oncology 57: 115-120, 1999 (IF 2,858)75. Caraceni A, Portenoy RK, a Working group of the IASP Task Force on Cancer Pain. AnInternational survey of cancer pain characteristics and syndromes. Pain 82: 263-274, 1999. (IF3,802)76. Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as adjuvant to opioid analgesia forneuropathic cancer pain J Pain Sympt Manage 17 (6) : 441-445, 1999. (IF 1,508)77. Maltoni M. Nanni O, Pirovano M et al Successful validation of the Palliative prognostic score interminally ill cancer patients. J Pain Symptom Manage 17: 240-247, 1999 vedi lista dei coautori(IF 1,508)5

78. Pirovano M, Maltoni M, Nanni O et al A new palliative prognostic score: a first step for the stagingof terminally ill cancer patients. J Pain Symptom Manage 17: 231-239, 1999 vedi lista deicoautori (IF 1,508)79. Caraceni A, Scolari S, Gallino G, Simonetti F. Meningeal metastases from malignant melanomapresenting with gaze-evoked tinnitus. Neurology 1999; 53: 2207-2208 * (IF 4,972)80. L. SAITA, D. POLASTRI, F. DE CONNO: Visual disturbances in advanced cancer patients: clinicalobservations. J.P.S.M. 17, 3, 224-226, 199981. BALZARINI, E. FELISI, A. MARTINI, F. DE CONNO: Efficacy of homeopathic tretment of skinreaction,s during radiotherapy for breast cancer: a randomised, double-blind clinical trial; BritishHomeopathic Journal, 88, 1-5, 199982. PERUSELLI, P. DI GIULIO, F. TOSCANI…………….F. DE CONNO, L. GROFF et al.: Homepalliative care for terminal cancer patients: a survey on the final week of life. Palliative Medicine,13, 233-241, 199983. M. COSTANTINI, F. TOSCANI, M. GALLUCCI…………….F. DE CONNO, L. GROFF et al.:Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohortstudy. J.P.S.M., vol. 18, 4, 243-252, 199984. T. TORELLI, M. COLAVITA, A. MILANI, G. PIZZOCCARO, S. NERVI, B. COTZA, R.CESTAROLLI, C. FICCARELLI, F. DE CONNO: Early rehabilitation of the perineal plane for thetreatment of incontinence after radical prostatectomy. International Journal of the Proctologicaland Perineal Diseases, III, 93-96, 199985. Caraceni, A., O. Nanni, Maltoni M, Piva L, Indelli M, Arnoldi E, Monti M, Montanari, L, Amadori D,De Conno, Italian Multicenter Study Group on Palliative Care The impact of delirium on the shorttermprognosis of advanced cancer patients. Cancer 89: 1145-1149, 2000. (IF 3,632)86. Defanti C.A and the ad hoc working group of the Italian neurological society. Study group ofbioethics and palliative care in neurology: program document Neurol Sci 2000; 21: 261-265 (IF 0)87. Ripamonti C, Zecca E, Brunelli C, Groff L, Boffi R, Caraceni A, Galeazzi G, Martini C, Panzeri C,Saita L, Viggiano V, De Conno F. Pain experienced by patients hospitalized at the NationalCancer Institute of Milan: research project "towards a pain-free hospital".Tumori. 2000 Sep-Oct;86(5):412-8. (IF 0,569)88. A. BALZARINI, C. SIGARI, F. DE CONNO: La terapia riabilitativa dell’edema dell’arto superiore.Linfologia, 4, 16-19, 200089. C. RIPAMONTI, S. MERCADANTE, L. GROFF, E. ZECCA, F. DE CONNO, A. CASUCCIO: Roleof octrotide, scopolamine butylbromide, and hydration in symptom control of patients withinoperable bowel obstruction and nasogastric tubes: a prospective randomised trial. J.P.S.M., 19,23-34, 200090. A. BALZARINI, E. FELISI, A. MARTINI, F. DE CONNO: Efficacy of homeopathic treatment of skinreactions during radiotherapy for breast cancer: a randomised, double blind clinical trial. BritishHomeopathic Journal, 89, 8-12, 200091. BALZARINI A., PLACUCCI P., CRABA L., CAMPANINI P., DE CONNO F. Trattamentoriabilitativo dei pazienti con tumore del distretto cervico-facciale. Attualità in Terapia Manuale &Riabilitazione, 3, 27-33, 200092. Grassi L, Caraceni A, Beltrami E, Zamorani M, Maltoni M, Monti M, Luzzani, M, Mercadante S, DeConno F. Assessing delirium in cancer patients the Italian versions of the Delirium Rating Scaleand the Memorial Delirium Assessment Scale. J Pain Symptom Manage 2001; 21: 59-68. (IF6

1,837)93. Caraceni A, Gorni G., Zecca E, De Conno F. More on the use of nonsteroidal anti-inflammatoriesin the management of cancer pain. J Pain Sympt Manage 2001; 21: 89-92 (IF 1,837)94. Caraceni, A., Evaluation and assessment of cancer pain and cancer pain treatment, ActaAnaesthesiol Scand, 45 (2001) 1067-1075 (IF 1,073)95. Hanks, G. de Conno F, Cherny N, Hanna, M. Kalso E, McQuay HJ, Mercadante S, Poulain P,Ripamonti C, Radbruch L, Roca I Casas J, Twycross RG, Ventafridda V and the steeringcommittee of the research Network of the EAPC* (De Conno Chair. A Caraceni, N Cherny, JFerraz Goncalves, CJ Furst, GW Hanks, S Kaasa, S Mercadante, JN Nunez Olarte, P Poulain, LRadbruch, C Ripamonti, F Stiefel) Morphine and alternative opioids in cancer patients the EAPCrecommendations Br J Cancer 2001; 84: 587-593 (IF 3,489)96. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay HJ, Mercadante S, Pasternak G,Ventafridda for the expert working group of the European Association of Palliative Care (DeConno Chair. A Caraceni, N Cherny, J Ferraz Goncalves, CJ Furst, GW Hanks, S Kaasa, SMercadante, JN Nunez Olarte, P Poulain, L Radbruch, C Ripamonti, F Stiefel, P. Thomas).Strategies to manage the adverse effects of oral morphine: an evidence-based report. J ClinOncol 2001; 19: 2542-2554 * (IF 8,773)97. RIPAMONTI C, TWYCROSS R., BAYNES M., BOZZETTI F., CAPRI S., DE CONNO F., GEMLOB., HUNT T., KREBS H., MERCADANTE S., SHAERER R., WILKINSON P.(Working group of theEuropean Association for Palliative Care): Clinical practice recommendations on the managementof bowel obstruction in patients with end-stage cancer. Supportive Care in Cancer, 9, 223-233,200198. FILIBERTI A, RIPAMONTI C, TOTIS A, VENTAFRIDDA V, DE CONNO F, CONTIERO P,TAMBURINI M. Characteristics of terminal cancer patients who committed suicide during a homepalliative care programme. J Pain Symptom Manage, 22, 544-553, 200199. HANKS GW., DE CONNO F., CHERNY N., HANNA M., KALSO E., MC QUAY HJ.,MERCADANTE S., MEYNADIER J., POULAIN P., RIPAMONTI C., RADBRUCH L., ROCA ICASAS J., SAWE J., TWYCROSS RG., VENTAFRIDDA V. and steering committee of the RN ofthe EAPC (De Conno chair, Caraceni, Cherny, Furst, Ferraz Gonsalves, Hanks, Nunez Olarte,Poulain, Radbruch, Ripamonti, Stiefel): Morphine and alternative opioids in cancer pain: theEAPC recommendations. BJC, 84, 587-593, 2001100. CHERNY N., RIPAMONTI C., PEREIRA J., DAVIS C., FALLON M., MC QUAY H.,MERCADANTE S., PASTERNAK G., VENTAFRIDDA V. and steering committee of the RN of theEAPC (De Conno chair, Caraceni, Cherny, Furst, Ferraz Gonsalves, Hanks, Nunez Olarte,Poulain, Radbruch, Ripamonti, Stiefel): Strategies to manage the adverse effects of oralmorphine: an evidence based report. J.C.O., 9, 2542-2554, 2001101. STIEFEL F., DIE TRILL M., BERNEY A., NUNEZ OLARTE JM., RAZAVI D. and thesteering committee of the RN of the EAPC (De Conno chair, Caraceni, Cherny, Furst, FerrazGonsalves, Hanks, Nunez Olarte, Poulain, Radbruch, Ripamonti, Stiefel): Depression in paliativecare: a pragmatic report from the expert working group of the EAPC. Support Care Cancer, 9,477-488, 2001102. BALZARINI A., CRABA L., PLACUCCI P., FAINI A., VIECELI C., DE CONNO F.:Valutazione statica e dinamica degli esiti da dissezione laterocervicale. Attualità in TerapiaManuale e Riabilitazione, Vlo. 3, 1, 31-34, 2001103. BALZARINI A., MILELLA M., CIVELLI E., SIGARI C., DE CONNO F.: Ultrasonography ofarm edema after axillary dissection for breast cancer: a preliminary report. Lymphology, in press7

104. Caraceni, A., Cherny, N., Fainsinger, R., Kaasa, S., Poulain, P., Radbruck, L., De Conno,F. and And-the-steering-committee-of-the-EAPC research-network, Pain measurement tools andmethods in clinical research in palliative care: recommendations of an expert working group of theEuropean Association of Palliative Care, J Pain Sympt Manage, 23 (2002) 239-255. (IF 2,119)105. Mercadante, S., Radbruch, L., Caraceni, A., Cherny, N., Kaasa, S., Nauck, F., Ripamonti,C., De Conno, F. and and-the-members-of-the-steering-committee-of-the-EAPC-researchnetwork,Episodic (breakthrough) pain. Consensus conference of an expert working group of theEuropean Association for Palliative Care, Cancer, 94 (2002) 832-839. (IF 3,909)106. Caraceni A, Galbiati A , Brunelli C, Gorni G, Martini C, Zecca E, De Conno F. Cancerpatients compliance in the self administration of a pain assessment tool J Pain Sympt Manage2004; 27: 417-424 (IF 1,885)107. Caraceni A, Martini C, Zecca , E, Portenoy RK, and a Working Group of an IASP TaskForce on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancerpain. An international survey. Pall Med 2004; 18: 177-183. (IF 1,185)108. Caraceni A., Zecca E, Bonezzi C, Arcuri E, Yaya Tur R, Maltoni M,Visentin M, Gorni G,Martini C, Tirelli W, Barbieri M, De Conno F. Gabapentin for neuropathic cancer pain: arandomized controlled trial from the gabapentin cancer pain study group J Clin Oncol 2004; 22:2909-2917 (IF 10,864)109. Caraceni A, Simonetti F Psychostimulants: new concepts for palliative care from themodafinil experience ? J Pain Sympt Manage 2004; 28: 97-99 (IF 1,885)110. Caraceni A, Andreola S , Simonetti F, Celio L. Acute confusional state with fatal outcomein a cancer patient. Neurol Sci 2003; 24 424-425(IF 0,907)111. Bianchi G.L., Vitali G., Caraceni A., Ravaglia S., Capri G., Cundari S., Zanna C., GianniL.: Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathyto oral acetyl-l-carnitine. Eur J Cancer 2005; 41: 1746-1750 (IF 3,302)112. Caraceni A., Brunelli C., Martini C., Zecca E., De Conno F.: Cancer pain assessment inclinical trials. A review of the literature (1999-2002). J Pain Symptom Manage 2005; 29: 507-519(IF 2,187)113. Klepstad P., Kaasa S., Cherny N., Hanks G., De Conno F and the research steeringcommittee of the EAPC.: Pain and pain treatments in European palliative care units. A crosssectional survey from the European Association for Palliative Care Research Network. Pall Med2005; 19: 477-484 [IF 1,268]114. Maltoni M., Caraceni A., Brunelli C., Broeckaert B., Christakis N., Eychmueller S.,GlareP., Nabal M., Viganò C., Larkin P., De Conno F., Hanks G., Kaasa S.: Prognostic factors inadvanced cancer patients: evidence-based clinical recommendations--a study by the SteeringCommittee of the European Association for Palliative Care. J Clin Oncol 2005; 23: 6240-6248 (IF9,835)115. Spinazzé S., Caraceni A., Schrijvers D.: Epidural spinal cord compression. Crit RevOncol Hematol 2005; 56: 397-406 (IF 2,667)116. Scaioli V, Caraceni A, Martini C, Curzi S, Capri G, Luca G.Electrophysiological evaluation ofvisual pathways in paclitaxel-treated patients. J Neurooncol. 2006; 77 :79-87 (IF 2,325)8

117. Bonito V, Caraceni A, Borghi L, Marcello N, Mori M, Porteri C, Casella G, Causarano R,Gasparini M, Colombi L, Defanti CA; SIN Bioethics and Palliative Care Study Group The clinicaland ethical appropriateness of sedation in palliative neurological treatments. Neurol Sci. 2005;26(5):370-85. (IF 0,779)118. Bosisio M, Caraceni A, Grassi L Italian Delirium Study Group.Phenomenology of delirium incancer patients, as described by the Memorial Delirium Assessment Scale (MDAS) and theDelirium Rating Scale (DRS). Psychosomatics. 2006 Dec;47(6):471-478. (IF 2,336)119. Cicero G, Fulfaro F, Caraceni A, Arcara C, Badalamenti G, Intrivici C, Gebbia N. A case ofGuillain-Barre syndrome in a patient with non small cell lung cancer treated with chemotherapy. JChemother. 2006 Jul;18(3):325-7. (IF 1,147)120. Holen JC, Hjermstad MJ, Loge JH, Fayers PM, Caraceni A, De Conno F, Forbes K, Furst CJ,Radbruch L, Kaasa S. Pain assessment tools: is the content appropriate for use in palliative care? J Pain Symptom Manage. 2006 Dec;32(6):567-80. (IF 2,309)121. Kaasa S, Torvik K, Cherny N, Hanks G, De Conno Patient demographic and centre descriptionin European palliative care units. A cross-sectional survey of the European Association forPalliative Care (EAPC) Research Network. Pall Med 2007; 21: 15-22 collective authorship (IF1,939)122. Gangeri L., Bosisio M., Brunelli C. Tamburini M., Serafin P., Clerici C. A., Caraceni A.,Mazzaferro V., “Phenomenology and emotional impact of neuropsychiatric symptoms in orthotopicliver transplant for hepatocellular carcinoma”, Transplantation Proceedings 2007 39: 1564-1568,(IF: 0,762)*123. Cavaletti G, Frigeni B, Lanzani F, Piatti M, Rota S, Briani C, Zara G, Plasmati R, Pastorelli F,Caraceni A, Pace A, Manicone M, Lissoni A, Colombo N, Bianchi G, group ftIN: The totalneuropathy score as and assessment tool for grading the course of chemotherapy-inducedperipheral neurotoxicity : comparison with the National Cancer Institute- Common Toxicity Scale.J Periph Nervous Syst 2007; 12: 210-215 (IF 2,065)124. Caraceni A, Zecca E, Martini C, Pigni A, Bracchi P Gabapentin for breakthrough pain due tobone metastases Pall Med 2008; 22: 392-393 (IF 1,652)125. Tassinari D, Montanari L, Maltoni M, Ballardini M, Piancastelli, A Musi M, Porzio G, Minotti V,Caraceni A, Poggi B, Stella A, Aielli F, Scarpi E. The palliative prognostic score and survival inpatients with advanced solid tumors receivig chemotherapy Supp Care Cancer 2008; 16: 359-370(IF 2,122)126. Kaasa S., Loge JH, Fayers P, Caraceni A, Strasser F, Hjermstadt M, Higginson I, Radbruch L,Haugen DK on behalf of EPCRC Symptom assessment in palliative care: a need for internationalcollaboration J Clin Oncol 2008; 23: 3867-3873 (IF 15,484)127. Hjemstad M, Gibbins J, Haugen DF, Caraceni A , Loge JH, Kaasa S, on behalf of the EPCRCEuropean Palliative Care Research Collaborative Pain Assessment tools in palliativ care anurgent need for consensus Pall Med 2008 22: 1-9 (IF 1,652)128. Bonito B, Primavera A, Borghi L, Mori M, De Fanti CA on behalf of the 23: 131-139e WorkingGroup on Bioethics and Palliative Care in Neurology Neurol Sci 2002; (?)129. Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, La Bianca R, Maltoni M, Nicora M,Torri V, Zucco F and the Cancer Pain Outcome Research Study Group, Pain in cancer. An out9

come research project to evaluate the epidemiology, the quality and the effects of pain treatmentin cancer patients. Health and Qualiy of Life Outcomes 2006 4: 7 doi: 10.1186/1477-7525-4-7(IF 0)130. Greco MT, Deandrea S, Corli O, Montanari M, Caraceni A, Apolone G a nome degliinvestigatori del Cancer Pain Outocome Research Study Group (CPOR SG) Effetti dellasomministrazione di buprenorfina transdermica in pazienti oncologici. Risultati di uno studio dioutcome Recenti Progressi in Medicina 2008; 99: 538-552 (IF 0)131. Caraceni A, Miccoli P, Martini C , Curzi S, Cresta S, Gianni L, Scaioli V. Peripheralneuropathy due to paclitaxel : study of the temporal relationship between the therapeutic scheduleand the clinical quantitative score (QST) and comparison with neurophysiological findings. JNeuroncol 2008; 86 : 89-99 (IF 1,856)132. Caraceni A, Simonetti F Palliating delirium in cancer patients Lancet Oncology 2009; 10:164-172 (IF 13,283)133. Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT; Cancer Pain OutcomeResearch Study Group (CPOR SG) Investigators, Apolone G, Bertetto O, Caraceni A, Corli O, DeConno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F. Effects of transdermalbuprenorphine on patients-reported outcomes in cancer patients: results from the Cancer PainOutcome Research (CPOR) Study Group. Clin J Pain. 2009 Oct;25(8):671-82. (IF 2,889)134. Apolone G, Corli O. ,Caraceni A, Negri E., Deandrea S, Montanari M, Greco MT, onbehalf of the Cancer Pain Outcome Research Study Group (CPOR SG) Investigators* Patternand quality of care of cancer pain management. Results from the Cancer Pain Outcome ResearchStudy Group (CPOR SG). Br J Cancer 2009; 100: 1566-1574 (IF 4,846)135. Knudsen AK, Aass N, Fainsinger R, Caraceni A, Klepstad P, Jordhøy M, Hjermstad MJ, KaasaS 1: Classification of pain in cancer patients--a systematic literature review. Palliat Med. 2009Jun;23(4):295 308. Epub 2009 Mar 13. (IF 1,874)136. Wasteson E, Brenne E, Higginson IJ, Hotopf M, Lloyd-Williams M, Kaasa S, Loge JH;European Palliative Care Research Collaborative (EPCRC). Depression assessment an dclassification in palliative cancer patients: a systematic literature review Palliat Med. 2009Dec;23(8):739-53. Epub 2009 Oct 13. Collaborators: Kaasa S, Skorpen F, Hjermstad MJ, LogeJH, Hanks G, Caraceni A, De Conno F, Higginson I, Strasser F, Radbruch L, Fearon K, SamoniggH, Bø K, Schaude M, Gundersen OE, Aaronson N, Baracos V, Fainsinger R, Stone PC, WilliamsML, Kaasa S, Dale O, Haugen DF. (IF 1,874)137. Beccaro M., Caraceni A., Costantini M., on behalf of the ISDOC Study Group: End-of- lifecare in Italian hospitals: quality of and satisfaction with care from the caregivers' point of view--results from the Italian Survey of the Dying of Cancer. J Pain Symptom Manage 2010; 39: 1003-1015 (IF 2,423)138. Brunelli C., Zecca E., Martini C., Campa T., Fagnoni E., Bagnasco M., Lanata L.,Caraceni A.: Comparison of numerical and verbal rating scales to measure pain exacerbations inpatients with chronic cancer pain. Health Qual Life Outcomes 2010; 8: 42 (IF 2,456)139. Caraceni A., Cavaliere F., Galante D., Landoni G.: A year in Review in MinervaAnestesiologica, 2009. Minerva Anestesiol 2010; 76: 158-168 (IF 1,614)10

140. Caraceni A., Zecca E., Martini C., Brunelli C., Pigni A., Gorni G., Galbiati A., Ibazeta M.,Hjermstad M., Kaasa S.: The validity of average 8-h pain intensity assessment in cancer patients.Eur J Pain 2010; 14: 441-445 (IF 3,612)141. Haugen D., Hjermstad M.J., Hagen N., Caraceni A., Kaasa S., European Palliative Care:Research Collaborative (EPCRC). Assessment and classification of cancer breakthrough pain: asystematic literature review. Pain 2010; 149: 476-482 (IF 5,371)142. Pigni A., Brunelli C., Gibbins J., Hanks G., Deconno F., Kaasa S., Klepstad P., RadbruchL., Caraceni A.: Content development for European guidelines on the use of opioids for cancerpain: a systematic review and Expert Consensus Study. Minerva Anestesiol 2010; 76: 833-843(IF 1,614)143. Galvan A, Skorpen F, Klepstad P, Knudsen AK, Fladvad T, Falvella FS, Pigni A, BrunelliC, Caraceni A, Kaasa S, Dragani TA. Multiple loci modulate opioid therapy response for cancerpain. Clin Cancer Res. 2011 17 (13) : 4581-7 May 27. [Epub ahead of print] PubMed PMID:21622719. (IF 7,338)144. Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R,Aass N, Kaasa S; European Palliative Care Research Collaborative (EPCRC). Studies comparingnumerical rating scales, verbal rating scales, and visual analogue scales for assessment of painintensity in adults: a systematic literature review. J Pain Symptom Manage. 2011 Jun;41(6):1073-93. PubMed PMID: 21621130. (IF 2,640)145. Fayers PM, Hjermstad MJ, Klepstad P, Loge JH, Caraceni A, Hanks GW, Borchgrevink P,Kaasa S; On behalf of the European Palliative Care Research Collaborative (EPCRC). Thedimensionality of pain: Palliative care and chronic pain patients differ in their reports of painintensity and pain interference. Pain. 2011 152: 1608 - 1620: 21458921. (IF 5,355)146. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M,Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM,Kaasa S; On behalf of the European Palliative Care Research Collaborative (EPCRC) and theEuropean Association for Palliative Care Research Network. Influence from genetic variability onopioid use for cancer pain: A European genetic association study of 2294 cancer pain patients.Pain. 2011 May;152(5):1139-1145. (IF 5,355)147. Raijmakers NJ, van Zuylen L, Costantini M, Caraceni A, Clark J, Lundquist G, Voltz R,Ellershaw JE, van der Heide A; on behalf of OPCARE9. Artificial nutrition and hydration in the lastweek of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol.2011 22: 1478 – 1486. (IF 6,452)148. Knudsen AK, Brunelli C, Kaasa S, Apolone G, Corli O, Montanari M, Fainsinger R, AassN, Fayers P, Caraceni A, Klepstad P; European Palliative Care Research Collaborative; EuropeanPharmacogenetic Study. Which variables are associated with pain intensity and treatmentresponse in advanced cancer patients?--Implications for a future classification system for cancerpain. Eur J Pain. 2011 Mar;15(3):320-7. (IF 3,819)149. Pigni A, Brunelli C, Caraceni A. The role of hydromorphone in cancer pain treatment: Asystematic review. Palliative Medicine, in press (IF 2,515)150. Caraceni A, Pigni A, Brunelli C. Is oral morphine still the first choice opioid for moderateto severe cancer pain? A systematic review within the European Palliative Care ResearchCollaborative Guidelines Project. Palliative Medicine, in press (IF 2,515)11

151. Radbruch L., Radbruch L, Trottenberg P, Elsner F, Kaasa S and Caraceni A. Asystematicreview on the role of alternative application routes for opioid treatment for moderate to severecancer pain: An EPCRC opioid guidelines project. Palliative Medicine, in press (IF 2,515)152. Mercadante S, Caraceni A Conversion ratios for opioid switching for the treatment ofcancer pain: EAPC Research Network recommendations.Palliative Medicine in press (IF 2,515)153. Kaasa S Apolone G, Klepstad P, Loge JH, Hjermstad M, Corli O, Strasser F, HeiskanenT, Costantini M, Zagonel V, Groenvold M., Fainsinger R, Jensen MP, Farrar JT, Mcquay, H,Rothrock N, Cleary J, Deguines C., Caraceni A , European Palliative care Collaborative (EPCRC)and the European Association for Palliative Care Research Network (EAPC RN) Expertconference in cancer pain assessment and classification the need for international consensus:working proposals on international standards BMJ Supportive and Palliative care 1: 3: 281-2872011154. Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F,Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M,Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D,Zeppetella G; European Palliative Care Research Collaborative (EPCRC); European Associationfor Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidencebasedrecommendations from the EAPC. Lancet Oncol. 2012 Feb;13(2):e58-68.155. Caraceni A, Bertetto O, Labianca R, Maltoni M, Mercadante S, Varrassi G, Zaninetta G,Zucco F, Bagnasco M, Lanata L, De Conno F, on Behalf of the Breakthrough/Episodic Pain ItalianStudy Group Episodic (breakthrough) pain prevalence in a population cancer pain patients.Comparison of clinical diagnosis with the QUDEI –Italian Questionnaire for Episodic Pain JournalPain Sympt Manage , 2012; 43 (5) 833-841 (IF 2,640)156. Caraceni A, Zecca, Martini C, Gorni G, Campa T, Brunelli C, De Conno F Palliativesedation at the end of life at a tertiary cancer centre Supportive Care in Cancer, Support CareCancer. 2012 Jun;20(6):1299-307. Epub 2011 Jul 16 (IF 2,089)157. Knudsen AK, Brunelli C, Klepstad P, Aass N, Apolone G, Corli O, Montanari M, CaraceniA, Kaasa S.Which domains should be included in a cancer pain classification system? Analysesof longitudinal data. Pain. 2012 Mar;153(3):696-703. Epub 2012 Jan158. Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role ofparacetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in thecontrol of pain in advanced cancer. A systematic review of the literature. Palliat Med. 2012Jun;26(4):305-12. Epub 2011 Nov 29159. Scarpi E, Maltoni M, Miceli R, Mariani L, Caraceni A, Amadori D, Nanni O. Survivalprediction for terminally ill cancer patients: revision of the palliative prognostic score withincorporation of delirium. Oncologist. 2011;16(12):1793-9. Epub 2011 Oct 31160. Raijmakers NJ, van Zuylen L, Costantini M, Caraceni A, Clark JB, De Simone G,Lundquist G, Voltz R, Ellershaw JE, van der Heide A on behalf of OPCARE9; Issues and needs inend-of-life decision making: An international modified Delphi study. Palliat Med. 2012Oct;26(7):947-953. Epub 2011 Oct 3.161. Hjermstad MJ, Lie HC, Caraceni A, Currow DC, Fainsinger RL, Gundersen OE, HaugenDF, Heitzer E, Radbruch L, Stone PC, Strasser F, Kaasa S, Loge JH; on behalf of the EuropeanPalliative Care Research Collaborative (EPCRC). Computer-Based Symptom Assessment Is12

Feasible in Patients With Advanced Cancer: Results From an International Multicenter Study, theEPCRC-CSA. J Pain Symptom Manage. 2012 Jul 13. [Epub ahead of print] 1:162. Corli O, Montanari M, Greco MT, Brunelli C, Kaasa S, Caraceni A, Apolone G. How toevaluate the effect of pain treatments in cancer patients: Results from a longitudinal outcomesand endpoint Italian cohort study. Eur J Pain. 2012 Dec 5. doi: 10.1002/j.1532-2149.2012.00257.x. [Epub ahead of print] PubMed PMID: 23213042.163. Rayment C, Hjermstad MJ, Aass N, Kaasa S, Caraceni A, Strasser F, Heitzer E,Fainsinger R, Bennett MI; On behalf of the European Palliative Care Research Collaborative(EPCRC). Neuropathic cancer pain: Prevalence, severity, analgesics and impact from theEuropean Palliative Care Research Collaborative-Computerised Symptom Assessment study.Palliat Med. 2012 Nov 21. [Epub ahead of print] PubMed PMID: 23175513. affiliation hospice V.Floriani164. Messina G, Rizzi M, Cordella R, Caraceni A, Zecca E, Bussone G, Franzini A, Leone M.Secondary chronic cluster headache treated by posterior hypothalamic deep brain stimulation:First reported case. Cephalalgia. 2012 Nov 19. [Epub ahead of print] PubMed PMID: 23165695.Pharmacogenet Genomics. 2013 Mar;23(3):117-126.165. Fladvad T, Klepstad P, Langaas M, Dale O, Kaasa S, Caraceni A, Skorpen F Variability inUDP-glucuronosyltransferase genes and morphine metabolism: observations from a crosssectionalmulticenter study in advanced cancer patients with pain. Pharmacogenet Genomics.2013 Mar;23(3):117-126.Senza IMPACT FACTOR1. Ventafridda V, Spoldi E, Caraceni A, Toscani F, De Conno F: Indicazione e limiti dellasomministrazione di morfina per via sottocutanea. Algos 3: 323-329, 1986.2. Ventafridda V., Spoldi E, Caraceni A, De Conno F: Percutaneous cordotomy and othermodalities. Ind J Pain 1: 127-135, 1986.3. Ventafridda V, Caraceni A, Spoldi E, Ripamonti C, Saita L, Toscani F, De Conno F: Gli oppioidinel dolore da cancro secondo la proposta dell'Organizzazione Mondiale della Sanita'. Algos 4:41- 47, 1987.4. Ventafridda V, Caraceni A, Saita L, De Conno F: WHO method for cancer pain relief. Ind J Pain2:78-81, 1987.5. Ventafridda V, Saita L, Oliveri E, Ripamonti C, Caraceni A et al: Somministrazione orale dimorfina in soluzione acquosa ed in compresse a lento rilascio nel dolore da cancro. Algos 5:66-71, 1988.6. Caraceni A: Compressioni midollari metastatiche: diagnosi e terapia. Argomenti di Oncologia 9:45-52, 1988.7. Ventafridda V, Spoldi E, De Conno F, Caraceni A: Trattamento farmacologico del dolore dacancro: gli oppioidi. Argomenti di Oncologia 9: 213-221, 1988.8. Ventafridda V, Caraceni A, Saita L, Bonezzi C, De Conno F, Gurise G, Ramella G., Silvani V,Tamburini M, Toscani F. Trazodone for deafferentation pain. Comparison with amitriptyline.Psychopharmacology 95: S44-S49, 1988. *13

9. Toscani F, Camerini S, Scazzina M, Caraceni A, De Conno F, Ripamonti C, Saita L, Spoldi E,Tamburini M, Corli O, Gallucci M. Valutazione clinica del trazodone nel trattamento del doloredisestesico nell neoplastico avanzato. Algos 6: 21-25, 1989.10. Pastena L, Caraceni A, Mainardi G., Gagliardi R, Faralli F, Brauzzi M, Fiorito A. Considerazioni suun caso di iperossia documentato con EEG. Annali di Medicina Navale XCV, 508-515, 1990.11. Pastena L, Gagliardi R, Maroni W, Brauzzi M, Caraceni A, Fiorito A, Mainardi G, Bernini Vanni P.Nuove metodolologie di rilevamento di dati elettrofisiologici in medicina subacquea e iperbarica.Annali di Medicina Navale XCV, 341-355, 199012. Da Poian SH, Caraceni A. Administracao subcutanea de Opioides. Rev Bras Anest, 41: 267-271,199113. Pastena L, Mainardi G, Caraceni A, Gagliardi R, Faralli F, Bernini Vanni P. L'attivita' elettricacerebrale durante respirazione di ossigeno normobarico e di ossigeno a 2,8 ATA. Annali diMedicina Navale XCVII: 37-48, 1992.14. Pastena L, Mainardi G, Seri S, Faralli F, Caraceni A, Matarese D, Gagliardi R. Confrontodell'attivita' elettroencefalografica durante due esperienze di saturazione (-205, -250). Giornale diMedicina Militare 5-6: 503-513, 1992.15. Caraceni A. Epidemiologia del dolore da cancro. Quaderni di Cure Palliative 2: 111-115, 1993.16. Caraceni A. La terapia del dolore da cancro avanzato dalla teoria alla pratica . Quaderni di CurePalliative 1: 53-54, 1993.17. Caraceni A. Multidisciplinarieta' per i sintomi neuropsichici nelle cure palliative ? Quaderni diCure Palliative 2: 89-90 1994.18. Caraceni A. (a cura di) Astenia e Sintomi Neuropsicologici. Quaderni di Cure Palliative 2, 2, 1994.19. De Conno F, Caraceni A, Ventafridda V, Aldrighetti L, Ferla G, Magnani G, Comi G. Reply to theletter by Dr. R.B. Traycoff et al. Pain 60: 234-235, 1995. *20. Caraceni A. Delirium in palliative medicine. Eur J Pall Care 1995; 2: 62-67.21. Caraceni A. Portenoy R.K. Oppioidi nel trattamento del dolore cronico non maligno Quaderni diCure Palliative 4: 361-367, 199522. Ventafridda V, Caraceni A, Sbanotto A. Cancer pain management. Pain reviews 3:153-179,1996.23. De Conno F, Caraceni A. Terapia con oppioidi nel dolore non maligno. Algia 1: 14-17 199724. De Conno F, Caraceni A. Terapia antalgica step by step Algia 1: 18-19.25. Caraceni A. Dispnea terminale. Due casi clinici, implicazioni terapeutiche ed etiche. Quaderni diCure Palliative 5: 250-254, 199726. Caraceni A. Dispnea terminale. Due casi clinici, implicazioni terapeutiche ed etiche. Quaderni diCure Palliative 5: 250-254, 199714

27. Caraceni A, De Conno F. Analgesic effects of chemotherapy ? (letter), J Clin Oncology 16: 803,1998.28. Caraceni A, Zecca E, Martini C, Brunelli C, Votta A, De Conno F. Analgesia controllata dalpaziente (PCA) per il controllo del dolore incidente nel paziente con cancro avanzato. RivistaItaliana di Cure Palliative 199929. Caraceni A. The contribution of neurophysiology to the diagnosis of leptomeningeal metastases.Neurol Sci 2000;21:65-66.30. Caraceni A, Zecca E, Martini C, De Conno F. Differences in gabapentin efficacy for cancer painmore apparent than real ? J Pain Symptom Manage 2001; 21: 93-94. letter31. Caraceni, A. and Weinstein, S.M., Classification of cancer pain syndromes, Oncology, 15 (2001)1627-1642.32. Bosisio, M., Caraceni, A., Grassi, L., Borreani, C., Mercadante, S., Luzzani, M., Maltoni, M. andCaraceni, A., Fenomenologia clinica del delirium nel paziente oncologico, Rivista Italiana di CurePalliative, 4 (2002) 17-30.33. Caraceni A. Scale di Valutazione Dolore Neuropatico 2005, 1: 13-2234. Caraceni A, Brunelli C, Martini C, Zecca E, De Conno F. Enhancing the quality of clinical trialsin cancer pain first requires that pain assessment methods are appropriately understood andused Br J Cancer 2006 (95) 1121. letter35. Cislaghi G.L., Brunelli C, Baiguini G, De Conno F, Caraceni A. Il trattamento professionaleShiatsu nell’assistenza alla persona ricoverata in Hospice. Rivista Italiana di Cure Palliative2007; 7 (2): 30-3536. Boffi R, Caraceni A, Portenoy R, Andersen H, Lonati G, De Conno F Attitudine didiverse categorie di medici italiani verso gli oppioidi RICP 2001 3 (4) : 209-21537. Caraceni A Le regole di fine vita in salsa olandese Janus 2008; 29: 60-6338. Kaasa S., Caraceni A.: Palliative cancer care research. Editorial Palliat Med 2010; 24: 259-260C Capitoli di libri1) Ventafridda V, Caraceni A et al: Cancer pain and mobility. In M Tiengo et al (eds) Advances in PainResearch and Therapy vol 10, Raven Press, New York, 1987 pp 135-146.2) Mancia M, Mariotti M,Caraceni A et al: Center- Median Parafascicularis thalamic complex andmediodorsal nucleus unitary responses to noxious stimuli and their conditioning by limbic andmesencephalic stimulations. In M. Tiengo et al (eds) Advances in pain Research and Therapy vol 10,Raven Press, New York, 1987 pp 17-29.3) Ventafridda V, Sbanotto A,Spoldi E, Caraceni A, De Conno F: Cancer pain management and drugdelivery. In Domellof L (ed) Drug Delivery in Cancer Treatment, Spinger Verlag, Berlin, 1987 pp 3-17.4) De Conno F, Caraceni A, Ventafridda V: Il dolore toracico e il suo trattamento sintomatico. In Ravasi G,Preda F (eds) Manuale di Oncologia Chirurgica Toracica, Casa Editrice Ambrosiana, Milano, 1988 pp15

281-286.5) Caraceni A , Spoldi E: Quadri clinici oncologici particolari. In Di Mola G (ed) Cure Palliative, Masson,Milano 1988: 73-80.6) Ventafridda V, Caraceni A, Sbanotto A, Spoldi E, De Conno F: Analgesic drugs in palliative care, InDomellof L (ed) Drug Delivery in Cancer Treatment II, Springer Verlag, Berlin, 1989 pp 3-13.7) Ventafridda V, Caraceni A, Gamba A: Summary of Demonstration Projects. Field testing of the WHOguidelines for cancer pain relief. In Foley K.M.et al Advances in Pain Research and therapy vol 16: 451 -464 1990.8) Ventafridda V, Caraceni A, Saita L, Spoldi E, De Conno F. Symptom control in palliative care. InDomellof L (ed) Drug Delivery in Cancer Treatment III, Springer Verlag, Berlin, 1991 pp 19 -39.9) Caraceni A, Martini C. Le funzioni cognitive. In Tamburini M (ed), La Valutazione della Qualita' di Vitain Oncologia. Masson, Milano 1990 pp 145 - 160.10) Ventafridda V, Saita L, Caraceni A, De Conno F. La terapia del dolore nei bambini con malattianeoplastica. In Assael BM (ed) Fisiopatologia e Terapia in Pediatria. Congress Studio, Milano, 1990 pp.785-79511) Ventafridda V, Saita L, Caraceni A, De Conno F. La terapia del dolore nei bambini con malattianeoplastica. In Assael BM (ed) Fisiopatologia e Terapia in Pediatria. II ed. Intramed Communications,Milano 1993 pp 247-25112) Ventafridda V, Caraceni A. Cancer Pain. In Prtvij Raj (ed). Current review on Pain. Current Medicine,Philadelphia, 1994 pp 155-178.13) Ventafridda V, Caraceni A, Tamburini M. Cure Palliative. In Staudacher V, Veronesi U, Andreoni B,Costa A (Eds) Manuale di Oncologia Chirurgica III edizione, Masson, Milano, 1994 pp 195-21714) De Conno F, Caraceni A, Ventafridda V. Principi di assistenza domiciliare. In Bonadonna G,Robustelli della Cuna, G (eds) Medicina Oncologica, V edizione, Masson, Milano, 1994 pp 1439-1443.15) Caraceni A, Martini C. Confusione mentale e sintomi neuropsichici nel paziente oncologico. InMercadante S (ed) Trattamento del dolore e dei sintomi nel cancro avanzato. Progressi Clinici: MedicinaVol 7, n. 6, Piccin, Padova, 1995 pp 189-203.16) Caraceni A., Martini C. Neurological Problems in Palliative Medicine. In Doyle D, MacDonald N, HanksG. Oxford textbook of Palliative Medicine II ed.. Oxford University Press, Oxford, 1998, pp 727-749.17) Caraceni A, Foley K M. La douleur du cancer et les syndromes douloureux du cancer. In Brasseur L.Chauvin M, Guilbaud G , (eds) Douleurs. Maloine, Paris, 1997 pp 567-587.18) Caraceni A , Spoldi E: Quadri clinici oncologici particolari. In Di Mola G (ed) Cure Palliative, Masson,Milano, 1994, pp 73-8119) Borreani C, Caraceni A, Tamburini M. The role of counselling for the confused patient and the family.In: Portenoy R.K., Bruera E. (Eds) Supportive Care Medicine vol 1. Oxford University Press 1997 pp 45-54.20) Ingham J.M., Caraceni A. Delirium In: Berger A., Levy M.H., Portenoy R.K., Weissman (Eds)Principles and practice of Supportive Care in Oncology Lippincott-Raven, Philadelphia, 1998, pp 477-49516

21) Caraceni A. Evaluation of cancer pain: multidimensional assessment and pain syndromes. In CampbelJ.N. (ed) "Pain 1996 An updated review. Refresher Course Syllabus." IASP Press, Seattle 1996 pp 219-237.22) Ceroni M, Simonetti F, Massimino M, Cefalo G, Caraceni A. I tumori cerebrali. In Amadori D, DeConno F, Maltoni M, Working expert group on guidelines for specific medical treatment in advancedcancer patients. Milano, UTET, 1999 pp 153-17223) Caraceni A. Le emergenze neurologiche. In Amadori D, De Conno F, Maltoni M, Working expert groupon guidelines for specific medical treatment in advanced cancer patients. Milano, UTET, 1999 266-27224) Caraceni A. Il dolore neuropatico nel paziente oncologico. In Buonocore M, Bonezzi C (curatori) Ildolore neurogeno dalla definizione alla terapia. Advances in rehabilitation vol 1 n 4 Maugeri FoundationBooks, Pavia pp 121-13025) Caraceni A, Foley F. Il dolore da cancro e le sindromi algiche neoplastiche. In In Brasseur L. ChauvinM, Guilbaud G , (eds) Dolori. Fondamenti di base farmacologia, dolori acuti e cronici, terapie. Mediserve,Milano, 1999 pp 567-587.26) Cheville A, Caraceni A, Portenoy, R.K. Pain definition and assessment. In Massie J.M. (Ed) Pain.What psychiatrists need to know. Review of Psychiatry vol 19. Washington American Psychiatric Press,2000: 1-22.27) Caraceni A, Cheville A, Portenoy RK. Pain management pharmacological and non-pharmacologicaltreatments. In: Massie JM, editor. Pain what psychiatrists need to know. Washington: AmericanPsychiatric Press, 2000:23-88.28) Martini C, Caraceni A. Valutazione del dolore. In: Mercadante S, Ripamonti C, editors. Valutazionediagnosi e trattamento del dolore da cancro. Milano: Masson, 2000:1-16.29) Martini C, Caraceni A. Sindromi dolorose in oncologia. In: Mercadante S, Ripamonti C, editors.Valutazione, diagnosi e trattamento del dolore da cancro. Milano: Masson, 2000:17-31.30) Caraceni A. Le compressioni midollari metastatiche. In: Masson, editor. Valutazione, diagnosi eterapia del dolore da cancro. Milano: Masson, 2000:156-168.31) Caraceni A, Portenoy R.K. Pain . In Joint R and Griggs R. (eds) Baker’s Clinical Neurology. Lippincott-Raven Publishers, Philadelphia PA, USA, ON CD ROMa) Edition 2003b) Edition 2004.32) Caraceni A, Martini C. Delirium e demenza in oncologia in Bellani, MC, Morasso, G, Amadori D, Orru’W., Grassi L., Casali PG, Bruzzi P et al Psicooncologia. Milano , Masson 2002 pp 701-71833) Ingham, J.M. and Caraceni, A., Delirium. In: A.M. Berger, R.K. Portenoy and D.E. Weissman (Eds.),Principles and practice of palliative care and supportive oncology, Lippincott Williams and Wilkins,Philadelphia, 2002, pp. 555-576.34) Caraceni A, Bosisio M, Ingham JM. Confusion and delirium In Schiff D. Wen PY (eds)Cancer Neurology in clinical practice. Totowa Humana Press 200235) Caraceni A., Bosisio M Acute confusional state. In Voltz R, Bernat JL, Borasio GD, Maddocks I,Oliver D, RK Portenoy Pallitive Care in Neurology Oxford, Oxford University Press 2004 pp 228-240.17

36) Grassi L., Caraceni A Delirium in Lelli G (Ed) Sintomi segnale in oncologia clinica. Monduzzi Editore,Ferrara 2005 pp 335-341.37) Caraceni A, Martini C, Simonetti F. Neurological problems in advanced cancer. In Doyle D, Hanks G.,Cherny N., Calman K. Oxford Textbook of Palliative Care. Oxford University Press, Oxford pp 702-726.38) Caraceni A, Martini C, Zecca E. Terapia del dolore In Bonadonna G, Robustelli Della Cuna G,Valagussa P Medicina oncologica 8° Edizione Elsevier Masson Milano 2007 pp 1881-189839) Caraceni A, Grond S. The development of the WHO analgesic ladder In Forbes K (ed.) Opioids incancer pain Oxford pain management library Oxford University Press Oxford 2007 pp 19-2440) Caraceni A, Bosisio M, Ingham JM. Confusion and delirium In Schiff D. Wen PY (eds)Cancer Neurology in clinical practice II edition. Totowa Humana Press 2008 pp 65-9041) Caraceni A, Matini C, Zecca E. La Misurazione del dolore. In Mercadante S. Il dolore valutazione,diagnosi e trattamento. Masson, Milano 2006 pp 65-7642) Caraceni A, Martini C, Zecca E. Dolore neuropatico. Terapia basata sull’evidenza. In Sghilanzoni A etal Terapia delle malattie neurologiche con principi di diagnosi. Edi Ermes , Milano 2004 pp. 299-30843) Maltoni M, Caraceni AT, Modonesi C. Prognostic indicators of survival In Bruera E, Higginson IJ,Ripamonti C, von Gunten CF. (eds.) Textbook of palliative medicine Hodder Arnold , London 2006 pp 965-97544) Simonetti F, Caraceni AT Seizures In Prognostic indicators of survival In Bruera E, Higginson IJ,Ripamonti C, von Gunten CF. (eds.) Textbook of palliative medicine Hodder Arnold , London 2006 pp 841-84845) Caraceni A, Martini C, Simonetti F. Neurological problems in advanced cancer. In Hanks G.,IVedition. Oxford University Press, Oxford 2010 pp 1034-105846) Faskvag Haugen D, Nauck F, Caraceni A. The core team and the extended team In Hanks G.,Cherny N., Christakis N, Fallon M, Kaasa S, Portenoy R. Oxford Textbook of Palliative Care IV edition.Oxford University Press, Oxford 2010 pp 167-17647) Caraceni A, Martini C, Zecca E. Cancer pain management and palliative care in Grisold W. Soffietti R(Eds) Neurooncology , Handbook of Clinical Neurology 3rd Edition Elsevier Handb Clin Neurol.2012;104:391-415..48) Licitra L, Vermorken JB, Specenier P. Caraceni A Systemic therapy i nthe treatment of recurrent andmetastatic head and neck carcinoma In Mehanna, HM and Kina Ang K. (eds) Head and neck cancerrecurrence Thieme Stuttgart New York 2012 ppMonografie/libri1) Gamba A, Caraceni A.T. Le scale analogiche visive. VAS - visual analogue scales, LASA -Linearanalogue self assessment. EdiSES, Napoli, 1992.18

2) Caraceni A, Spoldi E, De Conno F. l'infusione sottocutanea continua per il controllo del dolore e di altrisintomi nel paziente con cancro avanzato. Pharmacia ®3) De Conno F., Caraceni A. Manual of Cancer Pain. Kluwer Academic Publisher, Dordrecht 1996.4) De Conno F. Caraceni A. Dolore da cancro. Un manuale pratico. Raffaello Cortina, Milano 1997.5) Attal, N. Nicholson B, Serra J. (Eds), Baron R, Caraceni A, Glynn C., Harden N., Rowbotham, D.,Sjolund, B. (Contributing Faculty) New Directions in Neuropathic Pain. London Royal Society of MedicinePress, 2000.6) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2002 volune I Dolore oncologicoMilano Elsevier, 20027) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2002 volune II Dolore oncologicoMilano Elsevier, 20028) Caraceni A, Grassi L. Delirium – Acute confusional states in palliative medicine. Oxford, OxfordUniversity Press 20039) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2003 Dolore oncologico Farmaciper il controllo del dolore neuropatico in oncologia Milano Elsevier, 200310) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2004 Dolore oncologico Diagnosie valutazione del dolore neuropatico in oncologia Milano Elsevier, 200411) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2005 Dolore oncologico.Sindrome dolorosa dal lesione del nervo intercostobrachiale dopo chirurgia per tumore della mammellaMilano Elsevier, 200512) Caraceni A., Sghirlanzoni A., Simonetti F. Le complicazioni neurologiche in oncologia Springer-Verlag,Milano 200613) Walsh D. Caraceni A, Fainsinger R, Foley F , Glare P, Goh C, Lloyd-Williams M. Nunez Olarte JM,Radbruch L Palliative Medicine Saunders Elsevier, Philadelphia 200814) Caraceni A, Grassi L Delirum. Acute confusional states in palliative medicine 2 nd edition. OxfordUniversity Press, Oxford 201119